diabetes-mellitus

Documents about diabetes-mellitus

• Determinants of hypoglycemia and hospitalization among hemodialysis patients with type 2 diabetes: insights from a multicenter study in a resource-limited healthcare system#5091Europe PMC
• Assessment of quality of life in Gestational diabetes mellitus care - results of the pre-test of the disease-specific questionnaire GDM-QOL.#637NCBI PubMed Central
• Joint Modeling of Fasting Blood Sugar Changes and Cardiovascular Disease Progression in Type‐2 Diabetes Mellitus Patients: A Retrospective Cohort Study.#15186NCBI PubMed Central
• Video Training to Reduce Insulin Administration Errors#67800ClinicalTrials.gov
• Frequency and comorbidities of age-related macular degeneration in KSA: A retrospective multiregional study#127518Europe PMC
• A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics#136213ClinicalTrials.gov
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients#143749ClinicalTrials.gov
• Epidemiology and Associated Risk Factors of Diabetic Retinopathy in Patients with Diabetes Mellitus Attending a Tertiary-care Hospital in Hargeisa, Somaliland#147923Unpaywall
• T and B Cell Responses in Autoimmune Diseases#160277ClinicalTrials.gov
• Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg#162408ClinicalTrials.gov
• Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD#172531ClinicalTrials.gov
• Pengetahuan, Dukungan Keluarga, dan Perawatan Diri sebagai Prediktor Pengelolaan Diri Pasien DM#194609Jurnal Manajemen Kesehatan Yayasan RS.Dr. Soetomo
• A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin#143801ClinicalTrials.gov
• Additional file 5 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120742DataCite
• Additional file 5 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120743DataCite
• Additional file 4 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120744DataCite
• Additional file 4 of Traditional statistics and artificial intelligence-based prognostic models for predicting type 2 diabetes mellitus after gestational diabetes: a systematic review#120745DataCite
• Low-level laser and transcutaneous electrical nerve stimulation on salivary glands impact type 2 diabetes mellitus oral microbiome: an interim analysis of a randomized trial#187877Repositório Institucional da UnB
• Unusual outcome variances as a method to identify potentially problematic clinical trials#13957PLOS
• A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin#121287ClinicalTrials.gov
• A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)#126084ClinicalTrials.gov
• Barriers and facilitators for implementation of lifestyle related blended care interventions for overweight, obesity and type 2 diabetes mellitus: a scoping review.#143507NCBI PubMed Central
• A Comparative Study of the Effects of QS-M Needle Free Injector and Glargine Pen Subcutaneous Injection of Insulin Glargine on Insulin Use#143724ClinicalTrials.gov
• Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)#148655ClinicalTrials.gov
• Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)#160263ClinicalTrials.gov
• A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril#162342ClinicalTrials.gov
• Identification of Continuous Glucose Monitoring Self-Management Structured Education Programs for People with Type 1 Diabetes Mellitus: A Mixed Methodology Systematic Review.#193285NCBI PubMed Central
• Diabeloop for Kids#195472ClinicalTrials.gov
• Nurse-led Reminder Program for Therapy Adherence, Clinical Outcomes and Trust in Nurses in Diabetic Patients#201681ClinicalTrials.gov
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#123333Europe PMC
• A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal#158071ClinicalTrials.gov
• Award of the State of Kuwait Prize for the Control of Cancer, Cardiovascular Diseases and Diabetes in the Eastern Mediterranean Region [EM/RC68/INF.DOC.13]#190877WHO IRIS
• Impact of type 2 diabetes mellitus on in-hospital outcomes in patients with ST-elevation myocardial infarction: A nationwide study in Germany.#9635PubMed
• Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients#136300ClinicalTrials.gov
• Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial.#138557NCBI PubMed Central
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.#140948ClinicalTrials.gov
• The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients#143755ClinicalTrials.gov
• Spatial and temporal modeling of breast cancer mortality in Kansas: An R-INLA approach#143890PLOS
• Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS.#150087NCBI PubMed Central
• Hábitos alimentarios y actividad física en pacientes con diabetes tipo 2 atendidos ambulatoriamente en un Hospital Nacional de Huancayo, 2026#188142Repositorio Institucional
• Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets#18548ClinicalTrials.gov
• Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF#127792ClinicalTrials.gov
• Model of factors affecting self-management behaviors among pregnant women at risk of gestational diabetes mellitus, urban community in Bangkok: a structural equation modeling.#154510NCBI PubMed Central
• Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)#154856ClinicalTrials.gov
• Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study.#168181NCBI PubMed Central
• Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy#201683ClinicalTrials.gov
• GLUcose Transport and REnalPROtection in Chronic Kidney Disease#67851ClinicalTrials.gov
• GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers#123336Europe PMC
• Digital twin technologies for supporting self-care in adults with diet-related chronic conditions: a systematic review.#136095PubMed
• Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)#140943ClinicalTrials.gov